| Literature DB >> 35456323 |
Jibin Cao1, Simiao Li1, Lingling Cui1, Kexin Zhu1, Huaibi Huo1, Ting Liu1.
Abstract
To evaluate both left and right ventricular (LV and RV) function in patients with pulmonary arterial hypertension (PAH) using cardiac magnetic resonance tissue-tracking (CMR-TT) technology and explore its clinical value.Entities:
Keywords: CMR-TT; PAH; cardiac magnetic resonance tissue tracking; pulmonary arterial hypertension
Year: 2022 PMID: 35456323 PMCID: PMC9025312 DOI: 10.3390/jcm11082230
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Multiphase cine imaging was performed using a standard steady-state free precession (SSFP) pulse sequence in a 14-year-old male patient with pulmonary arterial hypertension (PAH). Four-chamber long-axis view at the end of diastole (A) and end of systole (B) and biventricular short-axis views at the end of the diastole (C) and the end of the systole (D).
Figure 2Cardiac magnetic resonance tissue tracking (CMR-TT) in the same patient with PAH shown in Figure 1. (A–C) Global radial strain of the ventricles in diastole. Color coding represents the tracking for the ventricle. (A) Right ventricle. (B) Left ventricle. (C) 3D model of the left and right ventricles in diastole. The color coding represents the epicardial contours. (D–F) Polar map of 2002 American Heart Association segmentation. (D) Radial strain (RS). (E) Circumferential strain (CS). (F) Longitudinal strain (LS). (G–I) Curve showing the strain values of the left ventricle in 25 phases, including the peak value. (G) RS. (H) CS. (I) LS.
Baseline clinical characteristics and cardiac function parameters in the PAH and healthy control groups.
| PAH Group ( | Healthy Control Group ( |
| |
|---|---|---|---|
| Age (years) | 49.32 ± 14.23 | 53.13 ± 15.06 | 0.258 |
| Gender (male/female) | 9/38 | 17/15 | <0.001 |
| Height (cm) | 164.00 ± 6.06 | 167.19 ± 7.28 | 0.059 |
| Weight (kg) | 60.26 ± 8.64 | 61.78 ± 10.27 | 0.167 |
| BMI (kg/m2) | 22.28 ± 1.69 | 21.94 ± 2.13 | 0.115 |
| Heart rate (bpm) | 69.68 ± 5.28 | 71.12 ± 5.92 | 0.561 |
| LVEF % | 62.29 ± 10.97 | 67.84 ± 6.90 | 0.013 |
| LVEDV (mL) | 85.60 ± 32.88 | 116.61 ± 24.70 | <0.001 |
| LVESV (mL) | 34.31 ± 26.20 | 37.74 ± 12.04 | 0.492 |
| RVEF % | 29.80 ± 8.30 | 47.92 ± 7.04 | <0.001 |
| RVEDV (mL) | 132.72 ± 43.41 | 106.16 ± 27.13 | 0.003 |
| RVESV (mL) | 94.74 ± 36.93 | 54.70 ± 16.53 | <0.001 |
Note: PAH, pulmonary arterial hypertension; BMI, body mass index; LV, left ventricular; RV, right ventricular; EDV, end-diastolic volume; ESV, end-systolic volume; EF, ejection fraction.
Figure 3Bland-Altman plots for interobserver variability. Bland-Altman plots for interobserver variability obtained for global LV strain and global RV strain. LV, left ventricular; RV, right ventricular; GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.
Interobserver consistency analyses.
| ICC | 95% CI |
| |
|---|---|---|---|
| LVGRS % | 0.976 | 0.932–0.991 | <0.01 |
| LVGCS % | 0.985 | 0.956–0.994 | <0.01 |
| LVGLS % | 0.819 | 0.540–0.929 | <0.01 |
| RVGRS % | 0.957 | 0.894–0.983 | <0.01 |
| RVGCS % | 0.947 | 0.867–0.979 | <0.01 |
| RVGLS % | 0.759 | 0.382–0.905 | <0.01 |
Note: ICC, interclass correlation coefficient; LV, left ventricular; RV, right ventricular; GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.
Comparison of myocardial strain values between the PAH and healthy control groups.
| PAH Group (n = 47) | Healthy Control Group (n = 32) | p | |
|---|---|---|---|
| LVGRS % | 32.37 ± 10.60 | 36.31 ± 7.92 | 0.077 |
| LVGLS % | −13.04 ± 3.49 | −16.79 ± 2.86 | <0.001 |
| LVGCS % | −18.01 ± 4.21 | −19.91 ± 2.90 | 0.027 |
| RVGRS % | 13.18 ± 5.21 | 24.33 ± 7.98 | <0.001 |
| RVGLS % | −11.81 ± 5.46 | −20.08 ± 6.41 | <0.001 |
| RVGCS % | −8.19 ± 3.10 | −13.30 ± 3.61 | <0.001 |
Note: LV, left ventricular; RV, right ventricular; GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain.
Figure 4Scatter plots of global radial strain (GRS) (A), global circumferential strain (GCS) (B), and global longitudinal strain (GLS) (C) in the left and right ventricles of PAH patients.
Comparison of RV strain parameters among PAH patients with reduced and preserved RV function and healthy controls.
| RVEF < 40% Group | RVEF ≥ 40% Group | Healthy Control Group |
| |
|---|---|---|---|---|
| RVGRS % | 12.31 ± 4.80 b | 16.85 ± 5.57 b | 24.33 ± 7.98 | <0.001 |
| RVGLS % | −11.13 ± 5.62 b | −14.70 ± 3.68 b | −20.08 ± 6.41 | <0.001 |
| RVGCS % | −7.71 ± 2.90 ab | −10.22 ± 3.26 b | −13.30 ± 3.61 | <0.001 |
| RVGCS-b % | −7.38 ± 3.85 | −7.58 ± 6.33 | −7.45 ± 8.52 | 0.996 |
| RVGCS-m % | −8.05 ± 4.40 ab | −11.49 ± 3.04 b | −15.36 ± 3.06 | <0.001 |
| RVGCS-a % | −6.38 ± 2.62 ab | −13.43 ± 4.18 b | −19.08 ± 5.49 | <0.001 |
| RVGRS-b % | 12.37 ± 4.28 b | 14.34 ± 8.22 b | 18.48 ± 7.53 | 0.001 |
| RVGRS-m % | 13.26 ± 6.32 b | 18.34 ± 5.73 b | 27.99 ± 11.90 | <0.001 |
| RVGRS-a % | 14.99 ± 4.94 b | 23.20 ± 8.96 b | 38.07 ± 18.69 | <0.001 |
Note: RV, right ventricular; GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain; GRS-a, apical GRS; GRS-m, mid-segment GRS; GRS-b, basal GRS; GCS-a, apical GCS; GCS-m, mid-segment GCS; GCS-b, basal GCS. a p < 0.05 vs. RVEF ≥ 40% group. b p < 0.05 vs. controls.
Comparison of LV strain parameters among PAH patients with reduced and preserved LV function and healthy controls.
| LVEF < 60% Group | LVEF ≥ 60% Group | Healthy Control Group |
| |
|---|---|---|---|---|
| LVGRS % | 21.97 ± 7.41 ab | 37.24 ± 8.06 | 36.31 ± 7.92 | <0.001 |
| LVGLS % | −10.51 ± 3.14 ab | −14.23 ± 3.01 b | −16.79 ± 2.86 | <0.001 |
| LVGCS % | −14.01 ± 3.76 ab | −19.89 ± 2.92 | −19.91 ± 2.90 | <0.001 |
| LVGCS-b % | −14.04 ± 3.46 ab | −18.74 ± 2.74 | −18.81 ± 2.75 | <0.001 |
| LVGCS-m % | −13.64 ± 3.63 ab | −19.26 ± 3.53 | −19.80 ± 3.06 | <0.001 |
| LVGCS-a % | −17.33 ± 5.42 ab | −24.82 ± 2.96 | −24.43 ± 4.29 | <0.001 |
| LVGRS-b % | 22.10 ± 7.00 ab | 33.57 ± 7.24 | 33.51 ± 7.31 | <0.001 |
| LVGRS-m % | 20.59 ± 6.85 ab | 34.84 ± 9.66 | 35.34 ± 9.04 | <0.001 |
| LVGRS-a % | 29.77 ± 14.37 ab | 57.17 ± 15.06 | 53.64 ± 18.10 | <0.001 |
Note: LV, left ventricular; GRS, global radial strain; GCS, global circumferential strain; GLS, global longitudinal strain; GRS-a, apical GRS; GRS-m, mid-segment GRS; GRS-b, basal GRS; GCS-a, apical GCS; GCS-m, mid-segment GCS; GCS-b, basal GCS. a p < 0.01 vs. LVEF ≥ 60% group. b p < 0.01 vs. controls.